Clinical Trial Update: Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial using the Medpulser Electroporation System with bleomycin for head and neck cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Bleomycin (bleomycin)
• Medpulser Electroporation System

Snippet

Sponsor: Inovio Pharmaceuticals | Conditions: Head and Neck Cancer | Phase 4 | Status: COMPLETED